Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
The NeuRx Diaphragm Pacing System, which may forestall the need for invasive ventilation, has been approved by the FDA for humanitarian use in ALS
Posted on Thursday, September 29, 2011 - 06:16, By: Amy Madsen
The U.S. Food and Drug Administration has approved the NeuRx Diaphragm Pacing System for treatment of hypoventilation (inadequate breathing) in amyotrophic lateral sclerosis (ALS).